COVID-19 Vaccine Safety Committee Holds Forum to Prepare for Full-Scale Review

Park Byung-joo, Chair of the COVID-19 Vaccine Safety Committee
[Photo by Yonhap News]

[Asia Economy Reporter Chunhee Lee] A forum to review the safety of COVID-19 vaccines will be held.

The COVID-19 Vaccine Safety Committee announced on the 26th that it will hold the '1st Forum of the COVID-19 Vaccine Safety Committee' in the afternoon at the Korean Society of Radiology conference room in Seocho-gu, Seoul. The forum will be broadcast live through the National Academy of Medicine of Korea's YouTube channel.

This forum is held to present and discuss research plans on research methodologies and evaluation criteria for vaccine safety assessment. In Part 1, Park Byung-joo, chairman of the Vaccine Safety Committee, will present the committee's research plans and trends in causality assessment of adverse reactions overseas through the presentation titled 'Introduction to the Study on Adverse Reaction Evaluation after COVID-19 Vaccination.'

In Part 2, Professor Jung Jae-hoon of the Department of Preventive Medicine at Gachon University College of Medicine will explain domestic and international vaccine adverse reaction monitoring systems under the theme of 'Causality Assessment Research Methodology.' Following this, Professor Choi Nam-kyung of the Department of Convergence Health Science at Ewha Womans University will present on pharmacoepidemiological research designs for adverse reaction evaluation and discuss research methodologies.

In the final Part 3, Professor Baek Kyung-ran of the Department of Infectious Diseases at Sungkyunkwan University School of Medicine will explain important clinical considerations when evaluating vaccine causality under the theme of causality assessment criteria. Professor Kim Dong-hyun of Hallym University College of Medicine's Department of Preventive Medicine will also present on causality judgment criteria based on epidemiological research results.

Through this forum, the committee plans to clarify the epidemiological association between vaccination and adverse events through large-scale observational studies on the Korean population and review principles for establishing guidelines that can determine causality in individual cases based on epidemiological associations.

Chairman Park Byung-joo said, "Since the public has great interest in the causality assessment of adverse reactions occurring after COVID-19 vaccination, we have prepared this opportunity to present and discuss the methodology plans of the research to be conducted by this committee," adding, "We will strive to create causality assessment criteria that can be internationally applicable, not only in Korea."

This content was produced with the assistance of AI translation services.